Medicare Enrolled
Dr. Jamie Dipietro, D.O., M.B.A
Urology Physician · Fresno, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dipietro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dipietro?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dipietro
Dr. Jamie Dipietro is an urology physician in Fresno, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Dipietro performed 11,045 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dipietro received a total of $13,435 from 51 pharmaceutical and/or device companies across 394 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dipietro is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 11% volume in CA
$13,435 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗11,045
Medicare services
Top 11% in CA for urology physician
Not available
Unique patients (not deduplicated)
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
3,800 | $5 | $12 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,550 | $0 | $0 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
904 | $2 | $6 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
549 | $9 | $66 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
458 | $96 | $280 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
416 | $101 | $270 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
212 | $69 | $190 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
206 | $136 | $375 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
119 | $201 | $529 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
105 | $8 | $8 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
80 | $25 | $58 |
| X-ray of body plane An X-ray imaging test that captures a specific plane or section of the body to visualize internal structures. |
75 | $77 | $196 |
| New patient office visit, complex (60-74 min) | 67 | $168 | $460 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
55 | $91 | $245 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
41 | $6 | $44 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
40 | $27 | $205 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
40 | $167 | $432 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
39 | $1 | $13 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
38 | $303 | $848 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
34 | $308 | $760 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
32 | $65 | $165 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 31 | $14 | $28 |
| Electronic analysis of implanted neurostimulator This procedure involves electronically analyzing an implanted neurostimulator generator and performing simple programming for spinal cord or peripheral nerve stimulation. |
30 | $34 | $106 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
26 | $331 | $848 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
24 | $162 | $428 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
22 | $72 | $186 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
16 | $109 | $834 |
| Cell examination of specimen, concentration technique A laboratory test that uses a concentration technique to examine cells from a specimen. |
13 | $33 | $135 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $45 | $120 |
| Insertion of peripheral or gastric neurostimulator generator A surgical procedure to implant the pulse generator device for a neurostimulator system. The generator is placed under the skin to deliver electrical impulses to nerves or the stomach. |
11 | $90 | $568 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.2% high complexity
73.0% medium
26.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,435
Total received (2018-2024)
Avg $1,919/year across 7 years
Top 15% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
394
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,214
2023
$1,000
2022
$2,988
2021
$1,663
2020
$2,307
2019
$2,176
2018
$2,087
Payments by company (2024)
Sumitomo Pharma America, Inc.
$275
BLUEWIND MEDICAL
$173
ABBVIE INC.
$132
Teleflex LLC
$103
Astellas Pharma US Inc
$90
UROGEN PHARMA, INC.
$78
Ferring Pharmaceuticals Inc.
$55
Janssen Biotech, Inc.
$55
COLOPLAST CORP
$51
Boston Scientific Corporation
$34
Tempus AI, Inc
$28
Bayer Healthcare Pharmaceuticals Inc.
$26
Tolmar, Inc.
$25
PROGENICS PHARMACEUTICALS, INC.
$24
Medtronic, Inc.
$22
Axonics, Inc.
$22
ACCORD HEALTHCARE, INC.
$22
Top 3 companies account for 47.8% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic USA, Inc.
$3,123
Medtronic, Inc.
$1,894
Axonics, Inc.
$1,363
Astellas Pharma US Inc
$971
Valencia Technologies Corporation
$876
Sumitomo Pharma America, Inc.
$656
Allergan Inc.
$578
Boston Scientific Corporation
$559
Allergan, Inc.
$320
Ferring Pharmaceuticals Inc.
$292
Avadel Specialty Pharmaceuticals, LLC
$255
TherapeuticsMD, Inc.
$248
UROVANT SCIENCES INC
$247
Uromedica, Incorporated
$192
BLUEWIND MEDICAL
$173
Antares Pharma, Inc.
$140
ABBVIE INC.
$132
Contura, Inc.
$130
Teleflex LLC
$117
UROGEN PHARMA, INC.
$92
AbbVie Inc.
$86
Olympus America Inc.
$74
AMAG Pharmaceuticals, Inc.
$69
Janssen Biotech, Inc.
$68
Supernus Pharmaceuticals, Inc.
$62
Endo Pharmaceuticals Inc.
$55
TOLMAR Pharmaceuticals, Inc.
$53
COLOPLAST CORP
$51
Merck Sharp & Dohme LLC
$40
Merck Sharp & Dohme Corporation
$39
Dendreon Pharmaceuticals LLC
$38
Mission Pharmacal Company
$28
Axonics Modulation Technologies, Inc.
$28
Progenics Pharmaceuticals, Inc.
$28
Tempus AI, Inc
$28
Bayer Healthcare Pharmaceuticals Inc.
$26
BOSTON SCIENTIFIC CORPORATION
$26
Duchesnay USA Incorporated
$25
Tolmar, Inc.
$25
PROGENICS PHARMACEUTICALS, INC.
$24
Novartis Pharmaceuticals Corporation
$24
UroGen Pharma, Inc.
$23
AstraZeneca Pharmaceuticals LP
$22
PALETTE LIFE SCIENCES, INC.
$22
ACCORD HEALTHCARE, INC.
$22
PFIZER INC.
$18
Janssen Pharmaceuticals, Inc
$17
Myovant Sciences Inc.
$17
Coloplast Corp
$16
Bayer HealthCare Pharmaceuticals Inc.
$12
Rochester Medical Corporation
$11
Top 3 companies account for 47.5% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ADVANTAGE FIT · AFINITOR · ALTIS · AVEED · Altis · Axonics · Axonics r-SNM System · BOTOX · BOTOX - UROLOGY · BOTOX THERAPEUTIC · Bulkamid · CAMCEVI · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL PELVIC ORGAN PROLAPSE · GENERAL FEMALE SUI · IMVEXXY · INTERSTIM · INTERSTIM ICON · INTRAROSA · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · Luja Coude · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Osphena · Otrexup · PREMARIN · PROVENGE · PYLARIFY · ProACT · REVI · SOLESTA · Uribel · UroLift System · Veozah · XIAFLEX · XTANDI · XYOSTED · Xofigo · eCoin Device Kit · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
18
County median income
$71,434
Nearest hospital to ZIP centroid (approximate)
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dipietro is a mixed practice specialist, with above-average Medicare volume (top 11% in CA), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dipietro experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Dipietro performed 3,800 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dipietro receive payments from pharmaceutical companies?
Yes. Dr. Dipietro received a total of $13,435 from 51 companies across 394 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dipietro's costs compare to other urology physicians in Fresno?
Dr. Dipietro's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dipietro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Fresno
Browse urology physicians in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology